Breakthrough Hemolysis Associated With COVID-19 Vaccination and Active COVID-19 Infection in a Patient With Paroxysmal Nocturnal Hemoglobinuria Maintained on Pegcetacoplan: A Case Report

Breakthrough hemolysis (BTH) is the return of hemolytic disease resulting in an overall increase in complement activation in a patient being treated for paroxysmal nocturnal hemoglobinuria (PNH) with complement inhibitors (CI). BTH after COVID-19 vaccination has only been reported in PNH patients tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Boshkos, Mitchell C, Fives, Kaila R, Phrathep, Davong D, Healey, Kevin D, Patel, Miten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103799/
https://www.ncbi.nlm.nih.gov/pubmed/37065335
http://dx.doi.org/10.7759/cureus.36240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10103799/
https://www.ncbi.nlm.nih.gov/pubmed/37065335
http://dx.doi.org/10.7759/cureus.36240

Ejemplares similares